2024年度の基調講演者：詳細情報
Shaping the Next Stage of Antibody Development with Complex Modalities and Combinations
複雑なモダリティと組み合わせによる、次の段階の抗体開発の具体化
Christian Klein, PhD
Roche Innovation Center
Immunotherapy Highlights
Taruna Arora, PhD
Bristol Myers Squibb
Multispecific Antibody Highlights
Tomoyuki Igawa, PhD
Chugai Pharmabody Research
ADC Highlights
Hironori Matsunaga, PhD
Daiichi Sankyo
PEGS EUROPEについて
PEGS Europeは1,500名以上の参加者が集まる、欧州最大のタンパク質・抗体エンジニアリング会議であり、「欧州で最高の生物製剤技術会議」とも評されています。今年の会議では、対象分野を人工知能/機械学習 (AL/ML) や多重特異性抗体、抗体・薬物複合体、さらには腫瘍関連の全ストリームまで広げています。2024年の会議の特徴は次の通りです：
COLLEAGUE TESTIMONIALS
“The best biologics technology meeting in Europe: a must-attend conference for novel biologics.”
Rakesh D., PhD, President & CEO, Bionavigen
“ I was very much impressed by the quality of the event, the depth and breadth of the presentations, as well as the scientific discussions and excitement. This is the event to participate and enjoy.”
Yan Q., PhD, Senior Principal Scientist, Rinat Pfizer
“Excellent event as usual. I always learn a substantial amount of info while at PEGS Europe.”
Christian K., PhD, Distinguished Scientist, Roche Innovation Center Zurich
“I truly enjoyed participating at the PEGS Congress. I have seen the quality and 'quantity' of the congress improving every year.”
Dario N., PhD, Full Professor, Chemistry and Applied Biosciences, ETH Zurich
